Home › NDC Lookup › RxCUI directory › RxCUI 2475199

Cabotegravir 30 MG Oral Tablet — RxCUI 2475199

RxNorm drug concept · Semantic clinical drug
RxCUI 2475199 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2475199
Official nameCabotegravir 30 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascabotegravir 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cabotegravir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It can actually be both, depending on the situation. If you already have HIV and your virus is under control on your current treatment, Vocabria tablets (taken with Edurant) serve...
  • What exactly is Vocabria used for — is it a treatment or a prevention drug?
  • This is a really important safety step. Cabotegravir on its own is not a complete HIV treatment — it only blocks one step the virus uses to replicate. If HIV somehow got into your...
  • Why do I have to keep getting HIV tested if I'm using this for PrEP?
📖 Read our full Cabotegravir guide →

🕸️ Concept Web — How Cabotegravir 30 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cabotegravir 30 MG Oral Tablet RxCUI 2475199

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Cabotegravir 2475077
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vocabria 2475200
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cabotegravir Oral Tablet 2475198
    • Cabotegravir Oral Product 2475196
    • Cabotegravir Pill 2475197
    • Cabotegravir Oral Tablet [Vocabria] 2475202
    • Vocabria Oral Product 2475203
    • Vocabria Pill 2475204
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cabotegravir 30 MG SCDC · 2475195
  • Cabotegravir Oral Tablet SCDF · 2475198
  • Cabotegravir Oral Product SCDG · 2475196
  • Cabotegravir Pill SCDG · 2475197

Brand-Name Concepts

  • Cabotegravir 30 MG Oral Tablet [Vocabria] SBD · 2475205
  • Cabotegravir 30 MG [Vocabria] SBDC · 2475201
  • Cabotegravir Oral Tablet [Vocabria] SBDF · 2475202
  • Vocabria Oral Product SBDG · 2475203
  • Vocabria Pill SBDG · 2475204
  • Vocabria BN · 2475200

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2475199 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
49702-0248-13 30 TABLET, FILM COATED in 1 BOTTLE (49702-248-13) Vocabria ViiV Healthcare Company 2021-01-21
Observed labelers: ViiV Healthcare Company (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.